Author:
Liu Jinwen,Li Shuyan,Ao Wuliji,Li Yongji,Xiao Yingge,Bai Meirong
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference25 articles.
1. Development and validation of a new RP-HPLC method for the determination of aprepitant in solid dosage forms;Nama;Trop. J. Pharmaceut. Res.,2011
2. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis;Cocquyt;Eur. J. Cancer,2001
3. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human;Wu;Int. J. Pharm.,2004
4. Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant;Olver;Int. J. Nanomed.,2007
5. A biopharmaceutical classification-based Right-Frist-time formulation approach to reduce human pharmacokinetic variability and project cycle time from Frist-In-Human to clinical Proof-Of-Concept;Ku;Pharmaceut. Dev. Technol.,2012
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献